The present disclosure relates to a light exposure monitoring system that includes a central control server; a plurality of indoor light exposure zones and a positioning system configured to communicate with the central control server to determine: a position (P) of an individual within the plurality of indoor light exposure zones, and a distance between a head of the individual and a floor within the plurality of indoor light exposure zones

A pharmaceutical composition for modifying a target structure, which includes at least one agent selected from the group consisting of energy modulation agents, plasmonics-active agents and combinations thereof; the energy modulation agents, when present, including one or more light emitters capable of emitting at least two different wavelengths of light, each wavelength of light associated with a different biological response, and the at least two different wavelengths capable of activating different biological responses; and a pharmaceutically acceptable carrier.

METHOD AND SYSTEM FOR CALCULATING ENERGY DOSES, PLATFORM FOR SHARING AND DISTRIBUTING ENERGY DOSES AND ENERGY DOSE

APPLICATION DEVICE The method (1000) comprises receiving (1010) parameters from an initial user; retrieving (1020) from a database (110) an initial dose based on the parameters of the initial user; adjusting (1030) the initial dose based on parameters of the initial user and a simulation of an effect of the initial dose on a standard organism, generating an adjusted initial dose; receiving (1040) feedback from the initial user regarding the effect of the adjusted initial dose; calculating (1050) a final dose based on the feedback from the initial user and the adjusted initial dose; receiving (1060) feedback from a target user regarding the effect of the final dose; calculating (1070) an adjusted final dose based on the feedback from the target user and the final dose.

A device for providing vestibular and somatosensory stimulation through bone conduction of sound waves to skeletal bones is provided in the form of a pad that is applied to or wrapped around the individual in treatment, which is comfortable in use and may contain particulate filler material capable of providing bone conduction stimulation adjacent to the location of a bone conduction transducer and expand the sound conduction site over a larger area. The device may be located beneath a pillow or mattress.

The present disclosure describes a method for neuromodulating a subject, comprising providing (i) a cognitively engaging content, and (ii) a gamma oscillation inducing waveform, wherein said gamma oscillation inducing waveform: comprises an intensity that renders said gamma oscillation inducing waveform imperceptible to said subject; and causes a therapeutic improvement in a cognitive function, thereby neuromodulating said subject.

An electronic device is disclosed comprising: a frame configured to be worn on a head of a user; a first light emitter mounted on the frame and configured to illuminate a first eye of the user, wherein an intensity and a spectrum of the first light emitter is adjustable; a second light emitter mounted on the frame and configured to illuminate a second eye of the user, wherein an intensity and a spectrum of the second light emitter is adjustable; a clock; a memory configured to store a target light profile comprising time-resolved data on an amount of light to be accumulated over time by the first and/or second eye of the user, wherein the time-resolved data comprises information about spectrum and intensity; and a controller configured to control the intensity and spectrum of the first and second light emitter based on the time and the target light profile.

An illumination device includes a light emitter configured to emit illumination light and a controller configured to control the light emitter. The controller controls the illumination light such that a first decrease ratio of melanopic illuminance of illumination light during night-time illumination to melanopic illuminance of illumination light during daytime illumination is higher than a second decrease ratio of illuminance of the illumination light during the night-time illumination to illuminance of the illumination light during the daytime illumination.

An illumination system adapted for an eyewear that includes a light source configured to emit a first light including a power spectrum having full width at half maximum of less than 100 nm in a first range of wavelengths and a second light including a power spectrum having full width at half maximum of less than 100 nm in a second range of wavelengths, the power spectrum of the first light and the power spectrum of the second light differ from each other, and the light source is further configured to emit pulses of light with a pre-determined time function. The pre-determined time function comprises a plurality of packets, each packet of the plurality of packets being followed by a packet interval, and each packet including a pulse alternation between a pulse of the first light and a pulse of the second light.

A veterinary lighting apparatus comprising: a heat sink on which are supported a plurality of LEDs for emitting light radiation, wherein the plurality of LEDs comprises at least one white light LED-emitter; at least one blue light LED-emitter; and at least one red light LED-emitter; and an activation means to switch on one or more of the white and/or blue and/or red light LED-emitters.

An illumination source, comprising: (a) at least one coherent light emitting device (CLED) configured for emitting coherent light having an optical path; (b) at least one optical element in said optical path for converting at least a portion of said coherent light to incoherent light, said optical element being configured to emit said incoherent light in a direction; and (c) a light control mechanism (LCM) for altering said direction of said incoherent light.